Weekly Update: New diabetes clinical trial (16 items)

New diabetes clinical trial: Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People Published on: August 24, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Oral semaglutide Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04524832?term=diabetes&sfpd_d=14 August 24, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) Published on: August 24, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: IMCY-0098 450 μg;   Drug: IMCY-0098 1350 μg;   Drug: Placebo Sponsor:   Imcyse SA Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04524949?term=diabetes&sfpd_d=14 August 24, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: A Cross-sectional Study to Estimate the Influence of Malnutrition, Diabetes Mellitus and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population Published on: August 26, 2020 at 07:00PM Conditions:   Mycobacterium Tuberculosis;   LTBI (Latent TB Infection);   Malnutrition;   Diabetes Mellitus;   Helminth Infections Intervention:   Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04526613?term=diabetes&sfpd_d=14 August 26, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Fenofibrate Versus Curcumin in Type 2 Diabetic Patients Published on: August 27, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Glimepiride Tablets;   Drug: glimepiride plus fenofibrate;   Drug: glimepiride plus curcumin Sponsor:   Rehab Werida Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04528212?term=diabetes&sfpd_d=14 August 28, 2020 at 01:24AM via ClinicalTrials.gov New diabetes clinical trial: Precise Treatment of Prediabetes and Stage 1 Hypertension Published on: August 27, 2020 at 07:00PM Condition:   Diabetes Intervention:   Sponsor:   Ruijin Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04529590?term=diabetes&sfpd_d=14 August 28, 2020 at 01:24AM via ClinicalTrials.gov New diabetes clinical trial: Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes Published on: August 27, 2020 at 07:00PM Conditions:   NAFLD;   Diabetes Mellitus, Type 2;   PreDiabetes Interventions:   Other: Customized diet to reduce liver fat;   Other: Healthy Nordic diet;   Other: Control Sponsor:   Uppsala University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04527965?term=diabetes&sfpd_d=14 August 28, 2020 at 01:24AM via ClinicalTrials.gov New diabetes clinical trial: Beneficial Effects of Quinoa (Chenopodium Quinoa Willd) in the Prevention of Type 2 Diabetes Mellitus Published on: August 27, 2020 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Dietary Supplement: Quinoa and quinoa-based food Sponsor:   Institut d'Investigacions Biomèdiques August Pi i Sunyer Completed https://clinicaltrials.gov/ct2/show/NCT04529317?term=diabetes&sfpd_d=14 August 28, 2020 at 01:24AM via ClinicalTrials.gov New diabetes clinical trial: Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System Published on: August 27, 2020 at 07:00PM Conditions:   Healthy;   Type 2 Diabetes Mellitus Intervention:   Device: Abbott Freestyle Libre Pro Sponsors:   Klick Inc.;   Mittal Global Clinical Trial Services Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04529239?term=diabetes&sfpd_d=14 August 28, 2020 at 01:24AM via ClinicalTrials.gov New diabetes clinical trial: GDM and Its Consequences in Mothers and Offsprings Published on: August 28, 2020 at 07:00PM Conditions:   Gestational Diabetes Mellitus;   Pregnancy Outcome;   Neurodevelopment;   Immune Development;   Childhood Obesity;   Host and Microbiome Intervention:   Sponsor:   Guangzhou Women and Children's Medical Center Recruiting https://clinicaltrials.gov/ct2/show/NCT04529889?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial Published on: August 28, 2020 at 07:00PM Conditions:   Type 2 Diabetes;   Obesity Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat Sponsor:   The Cleveland Clinic Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04531176?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Glucose Risk Assessment in Employer Populations Published on: August 28, 2020 at 07:00PM Conditions:   Diabetes;   Pre-diabetes;   Glucose Intolerance Intervention:   Device: Dexcom G6 Continuous Glucose Monitor (CGM) System Sponsor:   DexCom, Inc. Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04529824?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy Published on: August 28, 2020 at 07:00PM Conditions:   Diabetic Kidney Disease;   Diabetes Mellitus, Type 2;   Diabetic Nephropathies Intervention:   Drug: N Acetylcysteine Sponsor:   Al-Azhar University Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04531163?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years Published on: August 28, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04531462?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in Individuals With Recent-onset Type 2 Diabetes and Monogenic Diabetes Published on: August 28, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Dorzagliatin;   Drug: placebo Sponsor:   Chinese University of Hong Kong Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04531631?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt Published on: August 28, 2020 at 07:00PM Conditions:   Type 1 Diabetes;   Covid19 Intervention:   Sponsor:   Ain Shams University Recruiting https://clinicaltrials.gov/ct2/show/NCT04531111?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Home Intervention and Social Precariousness in Childhood Diabetes Published on: August 28, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Behavioral: Intervention by a pediatric nurse at the child's home Sponsor:   University Hospital, Bordeaux Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04530292?term=diabetes&sfpd_d=14 August 28, 2020 at 02:24PM via ClinicalTrials.gov

Weekly Update: a new vulnerability is published on the National Vulnerability Database (24 items)

New vulnerabilities from the NVD: CVE-2020-12644 OX App Suite 7.10.3 and earlier allows SSRF, related to the mail account API and the /folder/list API. Published at: August 31, 2020 at 06:15PM View on website August 31, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12643 OX App Suite 7.10.3 and earlier has Incorrect Access Control via an /api/subscriptions request for a snippet containing an email address. Published at: August 31, 2020 at 06:15PM View on website August 31, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-11618 THOMSON THT741FTA 2.2.1 and Philips DTR3502BFTA DVB-T2 2.2.1 set-top boxes have their TELNET service hardcoded to start on boot, which allows an attacker on the local network to achieve root access via the TELNET protocol. Published at: August 31, 2020 at 06:15PM View on website August 31, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-11617 The RSS application on THOMSON THT741FTA 2.2.1 and Philips DTR3502BFTA DVB-T2 2.2.1 set-top boxes doesn't validate the SSL certificates of RSS servers, which allows a man-in-the-middle attacker to modify the data delivered to the client. Published at: August 31, 2020 at 06:15PM View on website August 31, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14178 Affected versions of Atlassian Jira Server and Data Center allow remote attackers to enumerate project keys via an Information Disclosure vulnerability in the /browse.PROJECTKEY endpoint. The affected versions are before version 7.13.7, from version 8.0.0 before 8.5.8, and from version 8.6.0 before 8.12.0. Published at: September 01, 2020 at 08:15AM View on website September 01, 2020 at 01:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12776 Openfind Mail2000 contains Broken Access Control vulnerability, which can be used to execute unauthorized commands after attackers obtain the administrator access token or cookie. Published at: September 01, 2020 at 11:15AM View on website September 01, 2020 at 01:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2018-12475 A Externally Controlled Reference to a Resource in Another Sphere vulnerability in obs-service-download_files of openSUSE Open Build Service allows authenticated users to generate HTTP request against internal networks and potentially downloading data that is exposed there. This issue affects: openSUSE Open Build Service . Published at: September 01, 2020 at 03:15PM View on website September 01, 2020 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-5645 By sending a specially crafted HTTP GET request to a listening Rapid7 Metasploit HTTP handler, an attacker can register an arbitrary regular expression. When evaluated, this malicious handler can either prevent new HTTP handler sessions from being established, or cause a resource exhaustion on the Metasploit server. Published at: September 01, 2020 at 06:15PM View on website September 01, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2012-3341 IBM InfoSphere Guardium 7.0, 8.0, 8.01, and 8.2 is vulnerable to cross-site scripting, caused by improper validation of user-supplied input. A remote attacker could exploit this vulnerability using a specially-crafted URL to execute script in a victim's Web browser within the security context of the hosting Web site, once the URL is clicked. An attacker could use this vulnerability to steal the victim's cookie-based authentication credentials. IBM X-Force ID: 78294. Published at: September 01, 2020 at 08:15PM View on website September 01, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2012-3340 IBM InfoSphere Guardium 8.0, 8.01, and 8.2 is vulnerable to XML external entity injection, caused by improper validation of user-supplied input. A remote authenticated attacker could exploit this vulnerability to obtain sensitive information. IBM X-Force ID: 78291. Published at: September 01, 2020 at 08:15PM View on website September 01, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2012-3338 IBM InfoSphere Guardium 8.0, 8.01, and 8.2 could allow a remote attacker to bypass security restrictions, caused by improper restrictions on the create new user account functionality. An attacker could exploit this vulnerability to create unprivileged user accounts. IBM X-Force ID: 78286. Published at: September 01, 2020 at 08:15PM View on website September 01, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2012-3337 IBM InfoSphere Guardium 8.0, 8.01, and 8.2 could allow a remote attacker to traverse directories on the system. An attacker could send a specially-crafted URL request containing "dot dot" sequences (/../) to download arbitrary files on the system. IBM X-Force ID: 78284. Published at: September 01, 2020 at 07:15PM View on website September 01, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2012-3336 IBM InfoSphere Guardium 8.0, 8.01, and 8.2 is vulnerable to SQL injection. A remote authenticated attacker could send specially-crafted SQL statements to multiple scripts, which could allow the attacker to view, add, modify or delete information in the back-end database. IBM X-Force ID: 78282. Published at: September 01, 2020 at 07:15PM View on website September 01, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12621 The Teamwire application 5.3.0 for Android allows physically proximate attackers to exploit a flaw related to the pass-code component. Published at: September 02, 2020 at 08:15PM View on website September 02, 2020 at 09:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12058 Several XSS vulnerabilities in osCommerce CE Phoenix before 1.0.6.0 allow an attacker to inject and execute arbitrary JavaScript code. The malicious code can be injected as follows: the page parameter to catalog/admin/order_status.php, catalog/admin/tax_rates.php, catalog/admin/languages.php, catalog/admin/countries.php, catalog/admin/tax_classes.php, catalog/admin/reviews.php, or catalog/admin/zones.php; or the zpage or spage parameter to catalog/admin/geo_zones.php. Published at: September 03, 2020 at 05:15PM View on website September 03, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-10679 Thomson Reuters Eikon 4.0.42144 allows all local users to modify the service executable file because of weak %PROGRAMFILES(X86)%\Thomson Reuters\Eikon permissions. Published at: September 03, 2020 at 06:15PM View on website September 03, 2020 at 07:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-11579 An issue was discovered in Chadha PHPKB 9.0 Enterprise Edition. installer/test-connection.php (part of the installation process) allows a remote unauthenticated attacker to disclose local files on hosts running PHP before 7.2.16, or on hosts where the MySQL ALLOW LOCAL DATA INFILE option is enabled. Published at: September 03, 2020 at 09:15PM View on website September 03, 2020 at 11:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10720 A flaw was found in the Linux kernel's implementation of GRO in versions before 5.2. This flaw allows an attacker with local access to crash the system. Published at: September 03, 2020 at 09:15PM View on website September 03, 2020 at 11:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-11928 An input validation issue in WhatsApp Desktop versions prior to v0.3.4932 could have allowed cross-site scripting upon clicking on a link from a specially crafted live location message. Published at: September 04, 2020 at 12:15AM View on website September 04, 2020 at 01:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12248 In Foxit Reader and PhantomPDF before 10.0.1, and PhantomPDF before 9.7.3, attackers can execute arbitrary code via a heap-based buffer overflow because dirty image-resource data is mishandled. Published at: September 04, 2020 at 07:15AM View on website September 04, 2020 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-12247 In Foxit Reader and PhantomPDF before 10.0.1, and PhantomPDF before 9.7.3, attackers can obtain sensitive information from an out-of-bounds read because a text-string index continues to be used after splitting a string into two parts. A crash may also occur. Published at: September 04, 2020 at 07:15AM View on website September 04, 2020 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-11493 In Foxit Reader and PhantomPDF before 10.0.1, and PhantomPDF before 9.7.3, attackers can obtain sensitive information about an uninitialized object because of direct transformation from PDF Object to Stream without concern for a crafted XObject. Published at: September 04, 2020 at 07:15AM View on website September 04, 2020 at 08:36AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-3881 Bundler prior to 2.1.0 uses a predictable path in /tmp/, created with insecure permissions as a storage location for gems, if locations under the user's home directory are not available. If Bundler is used in a scenario where the user does not have a writable home directory, an attacker could place malicious code in this directory that would be later loaded and executed. Published at: September 04, 2020 at 03:15PM View on website September 04, 2020 at 05:36PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-20916 The pip package before 19.2 for Python allows Directory Traversal when a URL is given in an install command, because a Content-Disposition header can have ../ in a filename, as demonstrated by overwriting the /root/.ssh/authorized_keys file. This occurs in _download_http_url in _internal/download.py. Published at: September 04, 2020 at 11:15PM View on website September 05, 2020 at 01:36AM via National Vulnerability Database

Weekly Update: New diabetes clinical trial (15 items)

New diabetes clinical trial: Effect of Green Tea Extract on Lipids in Patients With Type 2 Diabetes Published on: August 31, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Dyslipidemias;   Arterial Stiffness Interventions:   Dietary Supplement: Green tea extract;   Dietary Supplement: Placebo Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico Completed https://clinicaltrials.gov/ct2/show/NCT04532385?term=diabetes&sfpd_d=14 August 31, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes Published on: August 31, 2020 at 07:00PM Condition:   Cystic Fibrosis-related Diabetes Interventions:   Drug: Insulin;   Device: Continuous glucose monitor (CGM) Sponsors:   Jagdeesh Ullal;   Wake Forest University Health Sciences Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04533646?term=diabetes&sfpd_d=14 August 31, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Personalized Behavioral Nutrition Intervention in Older AAs With T2D Published on: August 31, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Behavioral: ADA-based nutrition education with digital self-monitoring;   Behavioral: Personalized Behavioral Nutrition (PBN) intervention group Sponsors:   The University of Texas Health Science Center at San Antonio;   Asian Resource Center for Minority Aging Research (RCMAR) Recruiting https://clinicaltrials.gov/ct2/show/NCT04533659?term=diabetes&sfpd_d=14 August 31, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin Published on: September 01, 2020 at 07:00PM Conditions:   Diabetes;   Type 2 Diabetes Intervention:   Device: FreeStyle Libre Sponsor:   Northwell Health Recruiting https://clinicaltrials.gov/ct2/show/NCT04533945?term=diabetes&sfpd_d=14 September 01, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes Published on: September 01, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Other: Systematic screening for ischemic heart disease in type 2 diabetic patients Sponsor:   University Hospital, Bordeaux Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04534530?term=diabetes&sfpd_d=14 September 01, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy Published on: September 01, 2020 at 07:00PM Conditions:   Diabetic Nephropathies;   Diabetes Mellitus, Type 2;   Nephropathy, Diabetic Interventions:   Drug: APX-115;   Drug: Placebo Sponsor:   Aptabio Therapeutics, Inc. Recruiting https://clinicaltrials.gov/ct2/show/NCT04534439?term=diabetes&sfpd_d=14 September 01, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Time Limited Eating in Adolescents With Type 2 Diabetes Published on: September 02, 2020 at 07:00PM Conditions:   Time Restricted Feeding;   Pediatric Obesity;   Type 2 Diabetes;   Continuous Glucose Monitor Intervention:   Behavioral: Time Limited Eating Sponsor:   Children's Hospital Los Angeles Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04536480?term=diabetes&sfpd_d=14 September 02, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 Published on: September 02, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: Pioglitazone 30 mg;   Other: standard of care Sponsor:   Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04535700?term=diabetes&sfpd_d=14 September 02, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes Published on: September 02, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Flash Glucose Monitoring Intervention:   Device: Flash Glucose Monitoring System Sponsor:   Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting https://clinicaltrials.gov/ct2/show/NCT04535830?term=diabetes&sfpd_d=14 September 02, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt Published on: September 02, 2020 at 07:00PM Conditions:   Type 1 Diabetes;   Covid19 Intervention:   Sponsor:   Ain Shams University Completed https://clinicaltrials.gov/ct2/show/NCT04536285?term=diabetes&sfpd_d=14 September 02, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin Published on: September 03, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: Tirzepatide;   Drug: Insulin Lispro (U100);   Drug: Insulin Glargine (U100) Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04537923?term=diabetes&sfpd_d=14 September 03, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice Published on: September 03, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Oral Semaglutide Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04537624?term=diabetes&sfpd_d=14 September 03, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice Published on: September 03, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Oral Semaglutide Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04537637?term=diabetes&sfpd_d=14 September 03, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Serum Biomarkers Associated With Postpartum T2DM in Women With GDM Published on: September 04, 2020 at 07:00PM Condition:   Gestational Diabetes Intervention:   Sponsor:   First Affiliated Hospital, Sun Yat-Sen University Completed https://clinicaltrials.gov/ct2/show/NCT04539288?term=diabetes&sfpd_d=14 September 04, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus Published on: September 04, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: Semaglutide;   Drug: Insulin Degludec;   Drug: Insulin aspart Sponsors:   The Cleveland Clinic;   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04538352?term=diabetes&sfpd_d=14 September 04, 2020 at 02:24PM via ClinicalTrials.gov